Key result
Pretreatment with phloroglucinol for 28 days averted isoprenaline-induced myocardial infarction in rats by reducing ECG abnormalities, cardiac marker enzymes, and lipid peroxidation.
Why the study?
The cardioprotective potential of phloroglucinol against isoprenaline hydrochloride-induced myocardial infarction in rats was assessed.
Does pretreatment with phloroglucinol prevent isoprenaline-induced myocardial infarction in rats?
Does pretreatment with phloroglucinol prevent isoprenaline-induced myocardial infarction in rats?
Phloroglucinol pretreatment demonstrates cardioprotective effects against isoprenaline-induced myocardial infarction in a rat model.
Answers are grounded in this paper and cite their sources.
Phloroglucinol pretreatment attenuated injury in this rat model; hypothesis-generating and should not yet inform clinical practice.
Myocardial infarction (MI) is indicated by the symptoms like sharp chest pain, sweating, palpitations, and nervousness finally leading to heart attack. MI occurs mainly due to the risk factors like smoking, elevated blood pressure, diabetes, hypercholesterolemia, obesity, decreased HDL level, elevated LDL level, hyperlipoproteinemia and aging consequently leads to demandable coronary blood supply, oxidative stress, and acute necrosis of the myocardium. Cardioprotective potential of the phloroglucinol (PG) was assessed by treating isoprenaline hydrochloride (ISO; 85 mg/kg b.w., s.c.) induced MI model in rats. Pretreatment with PG in a dose of 30 mg/kg was done for 28 days and followed by ISO (for MI induction) on 29th and 30th days, exhibited decline in the abnormalities in the ECG patterns, cardiac marker enzymes, enzymic and nonenzymic antioxidants, lipid peroxidation, lipid profiles, and histopathological investigations compared to isoprenaline alone treated group. On the whole, the present investigations elucidate the significance of PG in alleviating the pathological process and appreciably prevent the induction of MI in experimental rats.
No takes yet. Share an insight, caveat, or question.
Zhu et al. (2019) studied Myocardial infarction. Phloroglucinol (PG) vs. Isoprenaline alone treated group was evaluated on Abnormalities in ECG patterns, cardiac marker enzymes, antioxidants, lipid peroxidation, lipid profiles, and histopathology. Pretreatment with phloroglucinol for 28 days averted isoprenaline-induced myocardial infarction in rats by reducing ECG abnormalities, cardiac marker enzymes, and lipid peroxidation.
Synapse has enriched 10 related papers. Consider them for comparative context: